Ισραήλ - Αγγλικά - Ministry of Health

rafa laboratories ltd - pralatrexate - solution for injection - pralatrexate 20 mg/ml - pralatrexate - pralatrexate - for the treatment of patients with relapsed or refractory peripheral t-cell lymphoma (ptcl).

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - pralatrexate, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium hydroxide - folotyn is indicated for the treatment of adult patients with peripheral t-cell lymphoma (nodal, extranodal, and leukaemic/disseminated) who have progressed after at least one prior therapy.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - pralatrexate, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; sodium hydroxide; sodium chloride; water for injections - folotyn is indicated for the treatment of adult patients with peripheral t-cell lymphoma (nodal, extranodal, and leukaemic/disseminated) who have progressed after at least one prior therapy.

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - formoterol fumarate dihydrate - inhalation powder - 12microgram

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - budesonide, quantity: 160 microgram/actuation; formoterol fumarate dihydrate, quantity: 5 microgram/actuation; glycopyrronium bromide, quantity: 9 microgram/actuation (equivalent: glycopyrronium, qty 7.2 microgram/actuation) - inhalation, pressurised - excipient ingredients: calcium chloride dihydrate; distearoylphosphatidylcholine; norflurane - maintenance treatment to prevent exacerbations and relieve symptoms in adults with moderate, severe, or very severe chronic obstructive pulmonary disease (copd) who require treatment with a combination of an inhaled corticosteroid (ics), a long-acting beta2-agonist (laba), and a long-acting muscarinic antagonist (lama). breztri aerosphere 160/7.2/5 is not indicated for the initiation of therapy in copd.

Αυστραλία - Αγγλικά - APVMA (Australian Pesticides and Veterinary Medicines Authority)

4 farmers australia pty ltd - metalaxyl-m - emulsifiable suspension - metalaxyl-m phenylamide active 350.0 g/l - fungicide

Αυστραλία - Αγγλικά - APVMA (Australian Pesticides and Veterinary Medicines Authority)

farmalinx pty ltd - metalaxyl-m - unknown - metalaxyl-m phenylamide active 0.0 - active constituent

Αυστραλία - Αγγλικά - APVMA (Australian Pesticides and Veterinary Medicines Authority)

shandong rainbow international co ltd - metalaxyl - unknown - metalaxyl phenylamide active 0.0 - active constituent

Αυστραλία - Αγγλικά - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nufarm australia limited - metalaxyl-m - unknown - metalaxyl-m phenylamide active 0.0 - active constituent

Αυστραλία - Αγγλικά - APVMA (Australian Pesticides and Veterinary Medicines Authority)

industrias quimicas del valles, s.a. - metalaxyl - unknown - metalaxyl phenylamide active 0.0 - active constituent